A project involving the generation of induced pluripotent stem cells (iPSCs) from Norwegian patients with Parkinsons disease was recently featured on the evening news broadcast from the Norwegian Broadcasting Corporation (NRK). This project - a collaboration between neurologist Mathias Toft, project group leader at the Department of Neurology at Oslo University Hospital and Gareth Sullivan, group leader at the Stem Cell Center - aims to generate neurons from the patient-derived iPS cells and to investigate disease mechanisms in these. The project is an example of the activities supported by The Neuron Factory platform at the Norwegian Center for Stem Cell Research.
Published in major journals, first or last author from Oslo University Hospital.
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
Diabetes Care (in press)
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes
J Am Coll Cardiol, 74 (6), 774-782
A novel score to select patients for treatment in chronic hepatitis B: Results from a large Ethiopian cohort
J Hepatol (in press)